172478-00-1

Basic information

• Product Name: 3-N-Boc-3-N-Methylaminopyrrolidine
• Synonyms: 3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE;3-(N-METHYL-N-BOC-AMINO)PYRROLIDINE;3-(N-METHYL-N-TERT-BUTOXYCARBONYLAMINO)PYRROLIDINE;3-N-BOC-3-N-METHYLAMINO-PYRROLIDINE;3-(N-BOC-N-METHYLAMINO)PYRROLIDINE;3-N-Boc-3-N-methylamino-pyrrol;3-(N-TERT-BUTOXYCARBONYL-N-METHYL 98%;Tert-butyl methyl(pyrrolidin-3-yl)carbamate
• CAS NO: 172478-00-1
• Molecular Formula: C₁₀H₂₀N₂O₂
• Molecular Weight: 200.28
• Product Categories: 3-Aminopyrrolidines;3-Aminopyrrolidines (Racemic)
• Mol File: 172478-00-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 96°C 0,2mm
• Flash Point: 116.035 °C
• Appearance: /
• Density: 1,02 g/cm3
• Refractive Index: 1.468
• PKA: 9.85±0.10(Predicted)
• CAS DataBase Reference: 3-N-Boc-3-N-Methylaminopyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-N-Boc-3-N-Methylaminopyrrolidine(172478-00-1)
• EPA Substance Registry System: 3-N-Boc-3-N-Methylaminopyrrolidine(172478-00-1)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 172478-00-1(Hazardous Substances Data)

Usage

General Description

3-N-Boc-3-N-Methylaminopyrrolidine is a chemical compound that is often used in organic synthesis. It is a derivative of pyrrolidine and contains a Boc (tert-butoxycarbonyl) protecting group on the nitrogen atom and a methylamino group on the adjacent carbon. 3-N-Boc-3-N-Methylaminopyrrolidine is commonly used as a building block for the synthesis of various pharmaceuticals and other organic compounds. It is known for its ability to act as a nucleophile and undergo various reactions, making it a versatile tool in organic chemistry. Additionally, its Boc protecting group makes it stable and easy to handle, making it a valuable reagent for chemical synthesis.

InChI:InChI=1/C10H20N2O2/c1-8-6-5-7-12(8)11-9(13)14-10(2,3)4/h8H,5-7H2,1-4H3,(H,11,13)

Upstream product

• 96568-35-3 1-benzyl-3-(methylamino)pyrrolidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 172477-98-4 1-benzyl-3-<(t-butyloxycarbonyl)methylamino>-pyrrolidine 

Downstream Products

• 863401-94-9 tert-butyl methyl(1-(5-nitropyridin-2-yl)pyrrolidin-3-yl)carbamate 
• 946056-08-2 (1-{5-[(biphenyl-4-carbonyl)-amino]-pyridin-2-yl}-pyrrolidin-3-yl)-methyl-carbamic acid tert-butyl ester 
• 863401-75-6 methyl-[1-(4-nitro-phenyl)-pyrrolidin-3-yl]-carbamic acid tert-butyl ester 
• 643087-83-6 tert-butyl [1-(4-aminophenyl)pyrrolidin-3-yl]methylcarbamate 
• 863401-89-2 biphenyl-4-carboxylic acid [4-(3-methylamino-pyrrolidin-1-yl)-phenyl]-amide 
• 863401-88-1 (1-{4-[(biphenyl-4-carbonyl)-amino]-phenyl}-pyrrolidin-3-yl)-methyl-carbamic acid tert-butyl ester 
• 172478-04-5 3-methylamino-1-propionyl-pyrrolidine 
• 838871-78-6 tert-butyl {1-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]-pyrrolidin-3-yl}methylcarbamate 
• 762285-60-9 C₁₉H₃₀N₂O₂ 
• 859731-43-4 2-(3-(R/S)-(((tert-butoxycarbonyl)amino)methyl)-pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid 
• 895571-39-8 (1-{2-[7-(3-fluoro-benzenesulfonyl)-chroman-4-yl]-ethyl}-pyrrolidin-3-yl)-methyl-carbamic acid tert-butyl ester 
• 748183-11-1 tert-Butyl [1-(4-amino-2-chloro-3-fluorophenyl)pyrrolidin-3-yl]methylcarbamate 

Relevant articles and documents

DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.

Indazole-carboxamide compounds

The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Quinolinone compounds as 5-HT4 receptor agonists

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.